Shufeng Yu Selected Research

BMS-470539

1/2022	BMS-470539 Attenuates Oxidative Stress and Neuronal Apoptosis via MC1R/cAMP/PKA/Nurr1 Signaling Pathway in a Neonatal Hypoxic-Ischemic Rat Model.
1/2021	Activation of MC1R with BMS-470539 attenuates neuroinflammation via cAMP/PKA/Nurr1 pathway after neonatal hypoxic-ischemic brain injury in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shufeng Yu Research Topics

Disease

2	Infarction (Infarctions) 01/2022 - 01/2021
2	Hypoxia (Hypoxemia) 01/2022 - 01/2021
1	Brain Infarction 01/2022
1	Neuroinflammatory Diseases 01/2021
1	Atrophy 01/2021
1	Brain Injuries (Brain Injury) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Alkalosis 01/2021
1	Hyperthyroidism 01/2021

Drug/Important Bio-Agent (IBA)

2	BMS-470539IBA 01/2022 - 01/2021
1	5- (6'- triphenylphosphoniumhexyl)- 5,6- dihydro- 6- phenyl- 3,8- phenanthridinediammineIBA 01/2022
1	fluoro-jade CIBA 01/2022
1	AldosteroneIBA 01/2021
1	PotassiumIBA 01/2021
1	SodiumIBA 01/2021
1	AntibodiesIBA 01/2021
1	CalciumIBA 01/2021
1	ChlorineIBA 01/2021

Therapy/Procedure

2	Ligation 01/2022 - 01/2021